Skip to content

Patient-reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty

Patient-Reported Outcome Measures in Patient Underwent Total Hip and Knee Arthroplasty in Galeazzi Orthopaedic Institute Milano

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04960098
Enrollment
5816
Registered
2021-07-13
Start date
2016-01-12
Completion date
2050-12-31
Last updated
2021-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Knee Osteoarthritis, Prosthesis Survival

Brief summary

Registry of Galeazzi Orthopedic Institute: provides for the regular and systematic collection of all data (clinical and some PROMs) obtained from patients undergoing hip and knee arthroplasty to which questionnaires are proposed investigating the specific functional sphere of the joints undergoing surgery (Knee injuryOsteoarthritisOutcomeScore (KOOS-PS) and Hip injuryOsteoarthritisOutcomeScore (HOOS-PS) but also the sphere of general health (ShortForm health survey-12 (SF-12) and VisualAnalogueScale (VAS)) , in addition, of course, to the satisfaction rate.

Interventions

PROCEDUREarthroplasty

patient with hip and knee osteoarthritis underwent hip and knee arthroplasty

Sponsors

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* male and female * age more than 18 * patient underwent hip or knee arthroplasty

Exclusion criteria

* age less than 18 * comorbidity that can results in the difficulty to come back for the follow up

Design outcomes

Primary

MeasureTime frameDescription
outcome measurementspre operative to 10 yearsimprove evaluation of hip and knee arthroplasty monitoring patient reported outcome measurements before and after surgery.

Countries

Italy

Contacts

Primary ContactMichele Ulivi
micheleulivi@masn.com00390266214946

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026